| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |